Ackman drives bid for Botox maker Allergan

Bill Ackman plans to use his 10 per cent stake in Allergan to support a $50bn-plus cash and stock bid from Valeant Pharmaceuticals

Leave a Reply

Your email address will not be published. Required fields are marked *